BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32221803)

  • 1. Salivary metabolites to detect patients with cancer: a systematic review.
    Assad DX; Mascarenhas ECP; de Lima CL; de Toledo IP; Chardin H; Combes A; Acevedo AC; Guerra ENS
    Int J Clin Oncol; 2020 Jun; 25(6):1016-1036. PubMed ID: 32221803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients-a systematic review with meta-analysis.
    Nazar NSBM; Ramanathan A; Ghani WMN; Rokhani FB; Jacob PS; Sabri NEB; Hassan MS; Kadir K; Dharmarajan L
    Clin Oral Investig; 2024 Jan; 28(1):98. PubMed ID: 38225483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic accuracy of salivary biomarkers for oral cancer and potentially malignant disorders: A systematic review protocol].
    Madera M; Franco JVA; Solà I; Bonfill X; Arévalo-Rodriguez I
    Medwave; 2020 Jun; 20(5):e7938. PubMed ID: 32603320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary biomarkers in the diagnosis of breast cancer: A review.
    Porto-Mascarenhas EC; Assad DX; Chardin H; Gozal D; De Luca Canto G; Acevedo AC; Guerra EN
    Crit Rev Oncol Hematol; 2017 Feb; 110():62-73. PubMed ID: 28109406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary metabolomics for the diagnosis of periodontal diseases: a systematic review with methodological quality assessment.
    Baima G; Iaderosa G; Citterio F; Grossi S; Romano F; Berta GN; Buduneli N; Aimetti M
    Metabolomics; 2021 Jan; 17(1):1. PubMed ID: 33387070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Metabolomics for Systemic Cancer Diagnosis: A Systematic Review.
    Nijakowski K; Zdrojewski J; Nowak M; Gruszczyński D; Knoll F; Surdacka A
    Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary metabolomics for cancer detection.
    Sugimoto M
    Expert Rev Proteomics; 2020 Sep; 17(9):639-648. PubMed ID: 33140667
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolomics and detection of colorectal cancer in humans: a systematic review.
    Wang H; Tso VK; Slupsky CM; Fedorak RN
    Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
    Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
    Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary biomarkers for cancer diagnosis: a meta-analysis.
    Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Takkouche B; López-López R; Suárez-Cunqueiro MM; Muinelo-Romay L
    Ann Med; 2020; 52(3-4):131-144. PubMed ID: 32056455
    [No Abstract]   [Full Text] [Related]  

  • 12. Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review.
    Nijakowski K; Gruszczyński D; Kopała D; Surdacka A
    Metabolites; 2022 Mar; 12(4):. PubMed ID: 35448481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
    Hema Shree K; Ramani P; Sherlin H; Sukumaran G; Jeyaraj G; Don KR; Santhanam A; Ramasubramanian A; Sundar R
    Pathol Oncol Res; 2019 Apr; 25(2):447-453. PubMed ID: 30712193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completeness of Reporting of Systematic Reviews of Diagnostic Test Accuracy Based on the PRISMA-DTA Reporting Guideline.
    Salameh JP; McInnes MDF; Moher D; Thombs BD; McGrath TA; Frank R; Dehmoobad Sharifabadi A; Kraaijpoel N; Levis B; Bossuyt PM
    Clin Chem; 2019 Feb; 65(2):291-301. PubMed ID: 30237150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
    Zhang A; Sun H; Wang X
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis.
    Guerra EN; Acevedo AC; Leite AF; Gozal D; Chardin H; De Luca Canto G
    Oral Oncol; 2015 Sep; 51(9):805-18. PubMed ID: 26170140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
    Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
    Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Zhong L; Cheng F; Lu X; Duan Y; Wang X
    Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.